why choose us

Clinical Trials Search

Showing 11,480 of 132,656 result(s)
Effects of SEMG Biofeedback With Core Muscle Strengthening Exercises and Kinesiotaping on Diastasis Recti in Post-partum Women

Status: ACTIVE_NOT_RECRUITING

Condition: Diastasis Recti Abdominis

Interventions: Surface EMG activity will be recorded from the left and right abdominal muscles while the exercises will be performed in different positions.
Ele

Date: 2023-05-31

A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults

Status: NOT_YET_RECRUITING

Condition: Nicotine Dependence

Interventions: Use ACT on Vaping smartphone app

Date: 2023-05-31

Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men

Status: NOT_YET_RECRUITING

Condition: Sexually Transmitted Diseases

Interventions: Doxycycline is a moderate-spectrum, second-generation tetracycline that is generally well tolerated

Date: 2023-05-31

The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: for subcutaneous injection only

Date: 2023-05-31

Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction

Status: ACTIVE_NOT_RECRUITING

Condition: Transthyretin Amyloid Cardiomyopathy

Interventions: Echocardiography

Date: 2023-05-31

Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer

Status: Completed

Condition: Breast Cancer Stage III

Interventions: Whole breast ; chest wall and corresponding regional lymph node irradiation with dose of 42.4 Gy in 16 fractions

Date: 2023-05-31

Magnetocardiography in the Accurate Identification of Myocardial Infarction

Status: NOT_YET_RECRUITING

Condition: Chest Pain, Acute Coronary Syndrome, Myocardial Infarction

Interventions: inspection equipment for magnetocardiography

Date: 2023-05-31

A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China

Status: NOT_YET_RECRUITING

Condition: Non-Hodgkin Lymphoma

Interventions: Study drug will be administered intravenously with adjustment for body weight weekly over 28-day cycles.

Date: 2023-05-31

A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants

Status: COMPLETED

Condition: Human Immunodeficiency Virus Type 1 (HIV-1)

Interventions: CAB LA injectable suspension is a sterile white to slightly pink suspension containing 200 milligrams per milliliter (mg;mL) of GSK1265744 as fre

Date: 2023-05-31

Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study

Status: ACTIVE_NOT_RECRUITING

Condition: Human Immunodeficiency Virus Type 1 (HIV-1)

Interventions: It is a sterile white to slightly pink suspension containing 200 mg;mL of CAB as free acid for administration by intramuscular (IM) injection.

Date: 2023-05-31